93 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6160

BeiGene
US$120.404.6%-2.6%US$20.9bUS$167.44PS6.7xE62.3%n/a

512

Grand Pharmaceutical Group
HK$4.37-1.6%6.8%HK$15.3bHK$6.50PE6.4xE7.1%5.9%

1530

3SBio
HK$5.64-3.4%-19.0%HK$13.3bHK$8.04PE7.3xE14.6%4.4%

2877

China Shineway Pharmaceutical Group
HK$7.97-6.0%n/aHK$6.0bHK$14.49PE5xE9.8%7.3%

1681

Consun Pharmaceutical Group
HK$5.848.1%13.6%HK$4.8bHK$8.25PE5.2xE14.8%10.3%

2877

China Shineway Pharmaceutical Group
HK$7.97-6.0%n/aHK$6.0bHK$14.49PE5xE9.8%7.3%

3933

United Laboratories International Holdings
HK$8.88-3.5%9.1%HK$16.1bHK$12.50PE5xE1.7%6.9%

2359

WuXi AppTec
CN¥37.307.8%-56.4%CN¥113.7bCN¥55.06PE13.6xE12.9%2.5%

2126

JW (Cayman) Therapeutics
HK$1.25-8.1%-38.4%HK$505.3mHK$2.76PS2.7xE-1.8%n/a

3933

United Laboratories International Holdings
HK$8.88-3.5%9.1%HK$16.1bHK$12.50PE5xE1.7%6.9%

512

Grand Pharmaceutical Group
HK$4.37-1.6%6.8%HK$15.3bHK$6.50PE6.4xE7.1%5.9%

2877

China Shineway Pharmaceutical Group
HK$7.97-6.0%14.5%HK$6.0bHK$14.49PE5xE9.8%7.3%

2359

WuXi AppTec
CN¥37.307.8%-56.4%CN¥113.7bCN¥55.06PE13.6xE12.9%2.5%

1530

3SBio
HK$5.64-3.4%-19.0%HK$13.3bHK$8.04PE7.3xE14.6%4.4%

1530

3SBio
HK$5.64-3.4%-19.0%HK$13.3bHK$8.04PE7.3xE14.6%4.4%

512

Grand Pharmaceutical Group
HK$4.37-1.6%6.8%HK$15.3bHK$6.50PE6.4xE7.1%5.9%

3933

United Laboratories International Holdings
HK$8.88-3.5%9.1%HK$16.1bHK$12.50PE5xE1.7%6.9%

3320

China Resources Pharmaceutical Group
HK$4.85-7.1%-4.2%HK$30.5bHK$7.26PE7.3xE7.8%3.5%

3320

China Resources Pharmaceutical Group
HK$4.85-7.1%-4.2%HK$30.5bHK$7.26PE7.3xE7.8%3.5%

6160

BeiGene
US$120.404.6%-2.6%US$20.9bUS$167.44PS6.7xE62.3%n/a

2359

WuXi AppTec
CN¥37.307.8%-56.4%CN¥113.7bCN¥55.06PE13.6xE12.9%2.5%

6160

BeiGene
US$120.404.6%-2.6%US$20.9bUS$167.44PS6.7xE62.3%n/a

3320

China Resources Pharmaceutical Group
HK$4.85-7.1%-4.2%HK$30.5bHK$7.26PE7.3xE7.8%3.5%

2973

Sanai Health Industry Group
HK$0.360%n/aHK$37.2mn/aPE2.6xn/a0%
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.